Crossmark

When cure exists but access does not

Crossref DOI link: https://doi.org/10.1038/s41591-026-04396-5

Published Online: 2026-05-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Taher, Ali T. https://orcid.org/0000-0001-8515-2238
License Information

Text and Data Mining valid from 2026-05-18

Version of Record valid from 2026-05-18
More Information

Article History

First Online: 18 May 2026

Competing interests

: A.T.T. reports consultancy fees and research support from Agios Pharmaceuticals, Bristol Myers Squibb, Novo Nordisk, Pharmacosmos and Vifor Pharma.